211 related articles for article (PubMed ID: 30067426)
21. Enhancer remodeling activates NOTCH3 signaling to confer chemoresistance in advanced nasopharyngeal carcinoma.
Liu L; Deng P; Liu S; Hong JH; Xiao R; Guan P; Wang Y; Wang P; Gao J; Chen J; Sun Y; Chen J; Mai HQ; Tan J
Cell Death Dis; 2023 Aug; 14(8):513. PubMed ID: 37563118
[TBL] [Abstract][Full Text] [Related]
22. Identification of miRNA/mRNA-Negative Regulation Pairs in Nasopharyngeal Carcinoma.
Liu M; Zhu K; Qian X; Li W
Med Sci Monit; 2016 Jun; 22():2215-34. PubMed ID: 27350400
[TBL] [Abstract][Full Text] [Related]
23. Hippo pathway contributes to cisplatin resistant-induced EMT in nasopharyngeal carcinoma cells.
Li S; Zhang X; Zhang R; Liang Z; Liao W; Du Z; Gao C; Liu F; Fan Y; Hong H
Cell Cycle; 2017; 16(17):1601-1610. PubMed ID: 28749195
[TBL] [Abstract][Full Text] [Related]
24. Proteomic analysis of docetaxel resistance in human nasopharyngeal carcinoma cells using the two-dimensional gel electrophoresis method.
Peng X; Gong FM; Ren M; Ai P; Wu S; Tang J; Hu X
Anticancer Drugs; 2016 Sep; 27(8):748-55. PubMed ID: 27333594
[TBL] [Abstract][Full Text] [Related]
25. ARC is highly expressed in nasopharyngeal carcinoma and confers X-radiation and cisplatin resistance.
Wu P; Tang Y; He J; Qi L; Jiang W; Zhao S
Oncol Rep; 2013 Oct; 30(4):1807-13. PubMed ID: 23877130
[TBL] [Abstract][Full Text] [Related]
26. MiR-34b-3 and miR-449a inhibit malignant progression of nasopharyngeal carcinoma by targeting lactate dehydrogenase A.
Li H; Li X; Ge X; Jia L; Zhang Z; Fang R; Yang J; Liu J; Peng S; Zhou M; Xiang J; Zeng Z; Zhou W; Xiong W; Xiao G; Fang L; Li GY; Li Z
Oncotarget; 2016 Aug; 7(34):54838-54851. PubMed ID: 27458165
[TBL] [Abstract][Full Text] [Related]
27. Isoprenylcysteine carboxylmethyltransferase is associated with nasopharyngeal carcinoma chemoresistance and Ras activation.
Zhu Y; Hu Q; Li H
Biochem Biophys Res Commun; 2019 Aug; 516(3):784-789. PubMed ID: 31253403
[TBL] [Abstract][Full Text] [Related]
28. Proteomic features of potential tumor suppressor NESG1 in nasopharyngeal carcinoma.
Liu Z; Chen C; Yang H; Zhang Y; Long J; Long X; Fang W
Proteomics; 2012 Nov; 12(22):3416-25. PubMed ID: 22997098
[TBL] [Abstract][Full Text] [Related]
29. Proteome Differences between Hepatitis B Virus Genotype-B- and Genotype-C-Induced Hepatocellular Carcinoma Revealed by iTRAQ-Based Quantitative Proteomics.
Wei D; Zeng Y; Xing X; Liu H; Lin M; Han X; Liu X; Liu J
J Proteome Res; 2016 Feb; 15(2):487-98. PubMed ID: 26709725
[TBL] [Abstract][Full Text] [Related]
30. Identification of the proteins related to p53-mediated radioresponse in nasopharyngeal carcinoma by proteomic analysis.
Zeng GQ; Yi H; Li XH; Shi HY; Li C; Li MY; Zhang PF; Feng XP; Wan XX; Qu JQ; Xu Y; Sun Y; Chen ZC; Xiao ZQ
J Proteomics; 2011 Nov; 74(12):2723-33. PubMed ID: 21356337
[TBL] [Abstract][Full Text] [Related]
31. Long Noncoding RNAs and Messenger RNAs Expression Profiles Potentially Regulated by ZBTB7A in Nasopharyngeal Carcinoma.
Liu F; Wei J; Hao Y; Tang F; Jiao W; Qu S; He N; Cai Y; Lan J; Yang Y; Wang Y; Li M; Weng J; Li B; Lu J; Han X
Biomed Res Int; 2019; 2019():7246491. PubMed ID: 31309112
[TBL] [Abstract][Full Text] [Related]
32. MiR-1204 sensitizes nasopharyngeal carcinoma cells to paclitaxel both in vitro and in vivo.
Peng X; Cao P; Li J; He D; Han S; Zhou J; Tan G; Li W; Yu F; Yu J; Li Z; Cao K
Cancer Biol Ther; 2015; 16(2):261-7. PubMed ID: 25756509
[TBL] [Abstract][Full Text] [Related]
33. CDK3 expression and its clinical significance in human nasopharyngeal carcinoma.
Wang L; Hu HY; Lin YL; Zhao ZX; Tan L; Yu P; Wan HJ; Jin Z; Zheng D
Mol Med Rep; 2014 Jun; 9(6):2582-6. PubMed ID: 24691537
[TBL] [Abstract][Full Text] [Related]
34. Omics-based identification of biomarkers for nasopharyngeal carcinoma.
Janvilisri T
Dis Markers; 2015; 2015():762128. PubMed ID: 25999660
[TBL] [Abstract][Full Text] [Related]
35. Mitochondrial proteomics of nasopharyngeal carcinoma metastasis.
Liu J; Zhan X; Li M; Li G; Zhang P; Xiao Z; Shao M; Peng F; Hu R; Chen Z
BMC Med Genomics; 2012 Dec; 5():62. PubMed ID: 23217164
[TBL] [Abstract][Full Text] [Related]
36. Proteomics-based identification of proteins with altered expression induced by 12-O-tetradecanoylphorbol 13-acetate in nasopharyngeal carcinoma CNE2 cells.
Jiang PZ; Gan M; Huang H; Shen XM; Wang S; Yao KT
Acta Biochim Biophys Sin (Shanghai); 2005 Feb; 37(2):97-106. PubMed ID: 15685366
[TBL] [Abstract][Full Text] [Related]
37. TRIM24 siRNA induced cell apoptosis and reduced cell viability in human nasopharyngeal carcinoma cells.
Wang P; Shen N; Liu D; Ning X; Wu D; Huang X
Mol Med Rep; 2018 Jul; 18(1):369-376. PubMed ID: 29749443
[TBL] [Abstract][Full Text] [Related]
38. Proteomic analysis of a nasopharyngeal carcinoma cell line and a nasopharyngeal epithelial cell line.
Huang PY; Zeng TT; Li MQ; Ban X; Zhu YH; Zhang BZ; Mai HQ; Zhang L; Guan XY; Li Y
Tumori; 2015; 101(6):676-83. PubMed ID: 26108243
[TBL] [Abstract][Full Text] [Related]
39. Lectin affinity chromatography and quantitative proteomic analysis reveal that galectin-3 is associated with metastasis in nasopharyngeal carcinoma.
Aimjongjun S; Reamtong O; Janvilisri T
Sci Rep; 2020 Oct; 10(1):16462. PubMed ID: 33020562
[TBL] [Abstract][Full Text] [Related]
40. MicroRNA-124-3p inhibits the growth and metastasis of nasopharyngeal carcinoma cells by targeting STAT3.
Xu S; Zhao N; Hui L; Song M; Miao ZW; Jiang XJ
Oncol Rep; 2016 Mar; 35(3):1385-94. PubMed ID: 26707908
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
